We are live on ! Find out more
KC

Kryger Capital Portfolio holdings

AUM $1.75B
1-Year Est. Return 102.57%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+102.57%
3 Year Est. Return
+420.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.75B
AUM Growth
+$339M
Cap. Flow
+$244M
Cap. Flow %
13.93%
Top 10 Hldgs %
74.92%
Holding
148
New
72
Increased
20
Reduced
17
Closed
39

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$72.8M
2
GTLS
Chart Industries
GTLS
+$71.1M
3
APGE icon
Apogee Therapeutics
APGE
+$66.9M
4
AES icon
AES
AES
+$66.7M
5
KVUE icon
Kenvue
KVUE
+$58.8M

Top Sells

Rank Stock Value
1
CWAN
Clearwater Analytics
CWAN
+$90.3M
2
DAWN
Day One Biopharmaceuticals
DAWN
+$83.5M
3
FOLD
Amicus Therapeutics
FOLD
+$65.9M
4
HOLX
Hologic
HOLX
+$62.1M
5
AL
Air Lease Corp
AL
+$57M

Sector Composition

Rank Sector Weight
1 Industrials 24.67%
2 Financials 22.06%
3 Communication Services 18.07%
4 Healthcare 12.34%
5 Consumer Staples 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSC icon
1
Norfolk Southern
NSC
$78.3B
$241M 13.75%
766,243
+235,974
+45% +$72.8M
GTLS
2
DELISTED
Chart Industries
GTLS
$186M 10.64%
892,579
+342,462
+62% +$71.1M
KVUE icon
3
Kenvue
KVUE
$36.8B
$163M 9.32%
8,549,767
+3,338,653
+64% +$58.8M
DBRG icon
4
DigitalBridge
DBRG
$2.99B
$142M 8.1%
9,002,375
+2,339,866
+35% +$36.6M
EA
5
DELISTED
Electronic Arts
EA
$141M 8.03%
686,759
+178,500
+35% +$36.2M
WBD icon
6
Warner Bros
WBD
$72.1B
$111M 6.34%
4,170,929
+1,084,098
+35% +$29.3M
AES icon
7
AES
AES
$10.5B
$100M 5.72%
6,840,535
+4,590,535
+204% +$66.7M
APGE icon
8
Apogee Therapeutics
APGE
$10.2B
$98.6M 5.62%
+742,555
New +$66.9M
SLAB icon
9
Silicon Laboratories
SLAB
$7.29B
$71.9M 4.1%
329,090
+149,703
+83% +$32.4M
ROKU icon
10
Roku
ROKU
$23.4B
$57.4M 3.27%
+415,486
New +$50.7M
BHF icon
11
Brighthouse Financial
BHF
$3.05B
$48.7M 2.78%
769,937
+267,203
+53% +$16.6M
NUVL
12
DELISTED
Nuvalent
NUVL
$35.4M 2.02%
+286,712
New +$30.8M
PEN icon
13
Penumbra
PEN
$12.7B
$33.9M 1.93%
107,207
-46,641
-30% -$15.1M
CZR icon
14
Caesars Entertainment
CZR
$6.06B
$29.2M 1.66%
+966,906
New +$27.3M
OGN icon
15
Organon & Co
OGN
$3.61B
$29.1M 1.66%
+2,152,693
New +$25.7M
TECH icon
16
Bio-Techne
TECH
$11.3B
$19.4M 1.11%
+274,290
New +$14.8M
ZKP
17
Lafayette Digital Acquisition Corp I
ZKP
$15.9M 0.91%
1,594,970
-27,161
-2% -$269K
MLAA
18
Mountain Lake Acquisition Corp II
MLAA
$12.6M 0.72%
+1,270,887
New +$12.7M
TDAC
19
Translational Development Acquisition Corp
TDAC
$209M
$12.2M 0.7%
+1,141,050
New +$12.2M
ILLU
20
Illumination Acquisition Corp I
ILLU
$312M
$9.78M 0.56%
+988,182
New +$9.77M
AEAQ
21
Activate Energy Acquisition Corp
AEAQ
$8.62M 0.49%
861,748
-57,825
-6% -$577K
AACO
22
Abony Acquisition Corp I
AACO
$8.32M 0.47%
+839,955
New +$8.31M
ALOV
23
Aldabra 4 Liquidity Opportunity Vehicle
ALOV
$375M
$7.41M 0.42%
+745,106
New +$7.38M
LEGO
24
Legato Merger Corp IV
LEGO
$312M
$7.4M 0.42%
+745,858
New +$7.38M
PSKY
25
Paramount Skydance Corp
PSKY
$12.2B
$7.39M 0.42%
+749,349
New +$7.89M
1
2 3 4 5

Similar funds

L7C
Liberty 77 Capital Washington, District of Columbia $1.75B AUM 88.73% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.75B AUM 33.61% 1-Year Est. Return
FTS
Fifth Third Securities Cincinnati, Ohio $1.75B AUM 21.97% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.75B AUM 41.21% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.75B AUM 57.75% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.76B AUM 16.47% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Kryger Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Kryger Capital held 148 positions worth $1.75B, up 24% from $1.41B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Kryger Capital deployed $244M of net new capital in Q2 2026, opening 72 new positions and adding to 20 existing holdings. Its largest new stake was Apogee Therapeutics: 742,555 shares worth $98.6M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Penumbra, an estimated $15.1M trimmed.

  • Kryger Capital's largest Q2 2026 buy was Apogee Therapeutics: 742,555 shares worth $98.6M.
  • Kryger Capital added most to Norfolk Southern in Q2 2026, an estimated $72.8M increase.
  • Kryger Capital's biggest Q2 2026 reduction was Penumbra, cutting an estimated $15.1M.
  • Kryger Capital fully exited Clearwater Analytics in Q2 2026, selling an estimated $90.3M.
  • Kryger Capital's ten largest holdings make up 75% of its $1.75B portfolio in Q2 2026.
  • Kryger Capital opened 72 new positions and closed 39 in Q2 2026.
  • Kryger Capital's portfolio value rose 24% quarter-over-quarter to $1.75B.

Based on Kryger Capital's 13F filing for Q2 2026, filed 14 Aug 2026.